Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: filgrastim|BIOLOGICAL: monoclonal antibody m170|DRUG: cyclosporine|DRUG: paclitaxel|PROCEDURE: peripheral blood stem cell transplantation|RADIATION: yttrium Y 90 monoclonal antibody m170
Sponsor: University of California, Davis